Paydirt
RE
Insider

Robert S Epstein

Director

Robert S Epstein (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $753K of VCYT (21,473 sh × $35.08, as filed), executed Oct 1 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
May 20
Filed May 22

Median ADV $55.3M across their filed names

Open performance
Volume by month
$753K$377K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $575KOct 2025 · sells $753KMay 2026 · sells $440K
Buys $0 Sells $1.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
VCYT Veracyte, Inc. VCYT · 0 buys · 3 sells 3 filings
Recent filings
VCYTSALE Veracyte, Inc. View filing → $440K
10,000 sh × $44.01
Exec May 20
Filed May 22 · 5:30 PM ET
VCYTSALE Veracyte, Inc. View filing → $753K
21,473 sh × $35.08
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET
VCYTSALE Veracyte, Inc. View filing → $575K
15,000 sh × $38.32
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET